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Abstract
Background: Dengue results in high morbidity and mortality globally. The knowledge, attitude and practices (KAP)
of dengue management, including diagnosis, among primary care physicians (PCPs) are important to reduce
dengue transmission and burden. However, there is a lack of understanding on the impact of dengue epidemic on
dengue management. Hence, the aim of this study is to examine the changes in KAP on dengue management
among PCPs before and after the largest dengue epidemic in 2013 in Singapore.
Methods: Surveys were mailed to 2000 and 1514 PCPs registered under the Singapore Medical Council in March of
year 2011 and 2014, respectively. Survey data were then collected between April and June of that year. Chi-square
or Fisher’s exact test was used for comparing categorical variables. A multivariate logistic regression model was
implemented to determine independent factors for frequent use of dengue diagnostic tests (DDTs). All tests were
conducted at 5% level of significance. Adjusted odds ratio and corresponding 95% confidence intervals were
reported, where applicable. Qualitative data were descriptively coded for themes and analysis.
Results: Among PCPs surveyed in 2011 and 2014, 89.9% and 86% had good knowledge on dengue management
respectively. The usage of DDTs had increased significantly in 2014 (N = 164;56%) as compared to 2011 (N = 107;29.
5%) in both private and public clinics (p < 0.001). Dengue Duo point-of-care test (POCT) kits was independently
associated with frequent use of DDTs (adjusted odds ratio = 2.15; 95% confidence interval = 1.25–3.69). There was a
significant reduction in referral of dengue patients to hospital (31.4% in 2011; 13.3% in 2014; p < 0.001), and a
significant increase in frequency of clinic follow-ups (18.4% in 2011; 28.5% in 2014; p = 0.003). One key theme
highlighted was that dengue management can be improved with availability of POCT kit, better awareness of the
disease and any revised clinical guidelines.
Conclusion: The knowledge on dengue management remained high, while the attitude and practices, particularly
on the usage of DDTs improved significantly after a large epidemic. Furthermore, PCPs had more confident in
managing dengue patients in primary care settings and in educating patients on the importance of vector control
and dengue warning signs to reduce dengue transmission and burden.
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Background
Dengue, one of the major global burdens, is estimated to
affect at least 50 million people annually [1]. Dengue
haemorrhagic fever (DHF) and Dengue shock syndrome
(DSS) are severe clinical manifestations for dengue infec-
tion in both adult and children. Identifying the disease
early and predicting the possible outcomes effectively is
a leading concern for Public Health specialists managing
the disease [2]
Dengue fever (DF) is endemic in the tropical and sub-
tropical regions, including Singapore [2]. Dengue was
first reported in Singapore in the early 1960 [3]. Since
1969, with the implementation of vector control and
surveillance, public health education and law enforce-
ment, there has been a general decline in disease inci-
dence, until in 1990 when dengue began to surge again
[4]. Since then, Singapore has faced several dengue epi-
demic. Spikes have been recorded in 2005 and 2007 with
14,209 and 8826 cases respectively [5]. The largest den-
gue epidemic was experienced in the year 2013 with
22,170 reported dengue cases with eight deaths [6]. In
Singapore, the occurrence of DF and DHF are influenced
by several factors such as lowered herd immunity and
virus transmission outside the home by Aedes mosqui-
toes, which potentially resulted in the resurgence of den-
gue incidences among adult population [7].
In 1997, the World Health Organization introduced
dengue management guidelines for diagnosis, treatment,
prevention and control [8]. A revised edition was released
in 2009 with updated information for better clinical
management, vector management and laboratory diagno-
sis [9]. Dengue virus infection may be asymptomatic or
symptomatic that may lead to unpredictable severe out-
comes such as death. In the three largest outbreak clusters
in Singapore, it was revealed that 73.2% of residents with
recent infection were asymptomatic [5]. Hence, early
detection of these dengue cases and monitoring of disease
severity are important parts of dengue management to
reduce dengue transmission and burden.
Moreover, to avoid over-hospitalization during an epi-
demic, it is important to have a system not only for early
detection but also effective outpatient monitoring. Since
the development of Dengue Duo POCT kit [10], there
were many clinical validation studies performed such as
the SD Dengue Duo POCT kit (Standard Diagnostics,
Inc., Gyeonggi-do, Korea) with sensitivities and specific-
ities ranging from 75.5–92.9% and 88.8–100% respectively
using frozen serum or plasma samples [11–14]. This
commercially available assay uses whole blood to obtain
dengue positivity result within 30 min of patient presenta-
tion. In 2013, SD Dengue Duo POCT kit was also
validated in Singapore with sensitivity and specificity of
93.9% and 92.0% respectively [15], with significant reduc-
tion (from estimated four hours to an hour) in the time
required from patient presentation to appropriate clinical
management in a tertiary hospital. This kit, which includes
both dengue NS1 antigen and dengue IgM & IgG anti-
body detection, is likely to enhance early diagnosis of den-
gue and reduce dengue burden at the primary healthcare
settings. A good understanding of the changes in KAP of
the dengue management among the PCPs will be import-
ant to reduce dengue burden. Even though there were two
cross-sectional KAP studies focusing on the dengue man-
agement of PCPs in Southern Vietnam [16] and Southern
Taiwan [17], there is still a lack of understanding on the
changes of KAP after a large dengue epidemic.
Therefore the aims of this study were to (1) Examine
changes in primary care physicians knowledge, attitude and
practices, in particular on the usage of dengue diagnostic
tests and related clinical practices; (2) Enquire about their
experience on using the POCT kit; (3) Gather recommen-
dations for improved service delivery in patient diagnostics
and clinical care management to facilitate reduction in
dengue burden.
Methods
Study design
Surveys were mailed to 2000 and 1514 PCPs registered
under the Singapore Medical Council in March of year
2011 [18] and 2014, respectively. Survey data were then
collected back between April and June of that year. The
survey form was developed by clinical researchers and
was piloted prior to the actual survey. A total of 364
(18.3%) and 293 (19.4%) surveys were mailed back in
2011 and 2014, respectively. We compared survey data
using baseline data collected in 2011 [18] and a follow-
up survey in 2014. The survey included open-ended
questions enquiring about the usage experience and/or
perception of the new POCT kit introduced in 2014 to
facilitate dengue diagnosis.
Survey questionnaire
The questionnaire was designed with four parts. They were
(1) practitioner demographics (gender, age, type of practice
and qualification), (2) dengue management – including re-
lated knowledge, dengue diagnostic practices, and clinical
care; (3) attitudes toward POCT and (4) responses to the
dengue epidemic in 2013. The baseline survey included 25
multiple-choice questionnaires [18]. However, only 18 of
these questions were retained in the 2014 survey so that
meaningful comparisons focusing on dengue management
can be performed (Additional file 1).
In relation to repertoires of disease management, partici-
pants were asked about their preferred method of dengue
diagnosis, the level clinical care of confirmed patients, and
their knowledge on dengue clinical guidelines. The dengue
warning signs recommended by the World Health
Organization used to classify Dengue into levels of severity
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was assessed [1]. These warning signs include: abdominal
pain or tenderness, persistent vomiting, clinical fluid accu-
mulation, bleeding/mucosal bleeding, drowsiness, fatigue,
lethargy, breathlessness, increase in haematocrit concurrent
with rapid decrease in platelet count and hepatomegaly.
Participants were asked about their awareness of the
warning signs and to list down three common ones.
In the follow-up survey in 2014, participants were
asked about their awareness on rapid Dengue POCT,
their level of interest in using it and any perceived chal-
lenges/benefits if they have experience using it. Two
open-ended questions were designed to seek partici-
pants’ opinion and experience about surge management,
and how participants had managed the 2013 epidemic
and the changes in dengue management after these den-
gue epidemics.
Analytic methods
Analysis was performed with consideration of both the
quantitative and qualitative data gathered in the survey. For
the quantitative analyses, the data were stratified by type of
practice, i.e. government subsidized polyclinic, private prac-
tice. Chi-square or Fisher’s exact test was used for compar-
ing categorical variables. A multivariate logistic regression
model was implemented to determine independent factors
for frequent use of DDTs. All tests were conducted at 5%
level of significance. We reported adjusted odds ratio and
corresponding 95% confidence intervals where applicable.
All statistical analyses were performed using SPSS Version
16 (SPSS Inc., Chicago, IL). Qualitative data were descrip-
tively coded for themes on the topics of the experience of
using the POCT kit, the management of dengue epidemics
and changes in dengue management after dengue epidemic.
NVivo 10 software Version 10, 2012 (QSR International Pty
Ltd.) was used to manage the textual data.
Results
Demographics characteristics of PCPs surveyed in 2011
and 2014
A total of 364 PCPs participated (18.3% response rate) in
the survey in 2011 [18]. A total of 293 PCPs participated
(19.4% response rate) in the survey in 2014 (Table 1).
Among these, majority were male (N = 157; 53.6%), and
were pre-dominantly in the age-group of 41–60 years old
(N = 185; 63.1%) and from the private sector (N = 206;
70.3%). There was significantly lesser male PCPs
(p = 0.046) in year 2014 (N = 157; 53.6%) than year 2011
(N = 223; 61.3%). There were significantly more PCPs in
the 41–60 years old group, but lesser in the above 60 years
old group (p < 0.0001) in the survey year 2014 (N = 185;
63.1% & N = 26; 8.9% respectively) than year 2011
(N = 185; 50.8% & N = 67; 18.4% respectively). The propor-
tion of PCPs with post-graduate degree qualifications was
significantly higher in survey year 2014 (N = 158; 53.9%)
than in 2011 (N = 124; 34.1%; p < 0.001; Table 1).
Table 1 Demographics of primary care physicians
Years 2011
N = 364 (%)
2014
N = 293 (%)
P value CFPS 2011a
N = 1400 (%)
Gender
Male 223 (61.3) 157 (53.6) 0.046 (60)
D.N.P. 3 (0.8) 1 (0.3)
Age
21–40 years 111 (30.5) 82 (28.0) (58) for <45 yrs
41–60 years 185 (50.8) 185 (63.1)
61 years or above 67 (18.4) 26 (8.9) <0.001 (42) for ≥45 yrs
D.N.P. 1 (0.3) 0
Highest Qualifications
M.B.,B.S. (or equivalent) only 231 (63.5) 133 (45.4) N.A.
Post-graduate degrees 124 (34.1) 158 (53.9) <0.001 N.A.
D.N.P. 9 (2.4) 2 (0.7)
Practice
Private 253 (69.5) 206 (70.3) (55.9)
Polyclinic 105 (28.8) 87 (29.7) 0.931 (44.1)
D.N.P. 6 (1.7) 0
Post-graduate degrees- Graduate Diploma in Family Medicine, Master in Medicine (Family Medicine), Membership of Royal College of Physicians
P values calculated by Fisher’s exact test. P value in bold represents a statistical significant difference
D.N.P. Data not provided by participants, M.B.B.S. Bachelor of Medicine and Bachelor of Surgery, N.A. Not available
aCFPS College of Family Physicians Singapore (As of June 2011) [24]
Pang et al. BMC Infectious Diseases  (2017) 17:428 Page 3 of 10
Knowledge on dengue warning signs and clinical
management
Majority of PCPs (N = 250; 86%) knew at least one of the
World Health Organization-guided dengue warning signs
in survey year 2014, which is significantly higher than in
year 2011 survey (N = 285; 78.3%; p = 0.024) (Table 2). The
top three responses in survey year of 2014 include the
bleeding/mucosal bleeding (N = 139; 55.6%) followed by
abdominal pain or tenderness (N = 97; 38.8%) and drowsi-
ness, fatigue, lethargy, breathlessness (N = 44; 17.6%)
(Additional file 2). Based on the three clinical scenarios
designed to assess the level of clinical management, the
majority of PCPs (75.7%) gave the preferred responses in at
least 2 questions (Additional file 3). In overall, 89.9% and
86% of the PCPs surveyed had good knowledge on dengue
management in 2011 and 2014 (p > 0.05), respectively.
Attitude and practices on dengue diagnostic tests
The proportion of the PCPs who always use DDTs, instead
of relying only on clinical diagnosis, increased significantly
in survey year 2014 (N = 164; 56%) compared to 2011
(N = 107; 29.5%; p < 0.001; Table 2). The proportion of
public PCPs who always use DDTs increased significantly
in survey year 2014 (N = 53; 60.9%) compared to 2011
(N = 9; 7.9%; p < 0.001). Moreover, the proportion of pub-
lic (0% in 2014 and 36.8% in 2011; p < 0.001) and private
(8.3% in 2014 and 17% in 2011; p = 0.008) PCPs who had
never used diagnostic testing decreased significantly in
survey year 2014 compared to survey year 2011. A signifi-
cantly higher proportion of PCPs (N = 236; 80.5%) used
DDTs in more than 50% of their consultations for sus-
pected dengue in survey year 2014 compared to year 2011
(N = 176; 48.5%; p < 0.001).
In 2011, about 74.8% (N = 211) of the PCPs relied on
Dengue serology (IgM/IgG) test in the laboratory as
Dengue Duo POCT kit was not available in the market
then. In 2014, after the introduction of Dengue Duo
POCT kit, about 37.7% (N = 104) of the PCPs used the
Dengue Duo POCT kit. Besides the Dengue Duo kit, Den-
gue serology (IgM/IgG) test and Dengue non-structural
antigen 1 assay test were frequently used in 2014 (N = 91,
33% and N = 62, 22.5% respectively). The proportion of
PCPs who used dengue reverse transcription- polymerase
chain reaction assay was significantly reduced in survey
year 2014 (N = 9, 3.3%) compared to survey year 2011
(N = 37, 13.1%; p < 0.001). These trends are similar in
both private and public polyclinics (Table 2).
Using data from 2014 survey, a multivariate logistic
regression was performed to identify factors associated
with frequent behaviour (comparing between ‘Always’ and
‘Sometimes/Never’ groups) of DDTs utilization. After
adjusting for confounding factors (gender, age, place of
Table 2 Dengue diagnostic practices among primary care physicians
Overall P value Private practice P value Polyclinic practice P value
2011
N = 364 (%)
2014
N = 293 (%)
2011
N = 253 (%)
2014
N = 206 (%)
2011
N = 105 (%)
2014
N = 87 (%)
WHO warning signs
Yes 285 (78.3) 250 (85.3) 0.024 N.A. 171 (83.4) N.A. N.A. 79 (91.9) N.A.
D.N.P. 3 (0.8) 2 (0.7) 2 (1) 1 (1.1)
Dengue Diagnostic Test (DDT)
Always (100%) 107 (29.4) 164 (56.0) <0.001 98 (38.7) 111 (53.9) 0.001 7 (6.7) 53 (60.9) <0.001
Often (51–99%) 69 (19.0) 72 (24.5) 0.086 51 (20.2) 52 (25.2) 0.216 17 (16.2) 20 (23.0) 0.274
Sometimes (1–50%) 105 (28.8) 40 (13.7) <0.001 61 (24.1) 26 (12.6) 0.002 41 (39) 14 (16.1) <0.001
Never (0%) 82 (22.5) 17 (5.8) <0.001 43 (17.0) 17 (8.3) 0.008 39 (37.1) 0 <0.001
D.N.P. 1 (0.3) 0 0 0 1 (1) 0
Dengue Diagnostic Test (DDT)
> 50% of the time 176 (48.4) 236 (80.5) <0.001 149 (58.9) 163 (79.1) <0.001 24 (22.9) 73 (83.9) <0.001
D.N.P. 1 (0.3) 0 0 0 1 (1) 0
Most Frequently Used DDT Among Those Who Reported Usage of DDT
Dengue serology (IgM/IgG) 211 (74.8) 91 (33) <0.001 144 (68.6) 59 (31.2) <0.001 62 (93.9) 32 (36.8) <0.001
Dengue non-structural antigen
1 (NS1) assay
31 (11) 62 (22.5) <0.001 29 (13.8) 47 (24.9) 0.003 1 (1.5) 15 (17.2) 0.002
Dengue RT-PCR 37 (13.1) 9 (3.3) <0.001 36 (17.1) 7 (3.7) <0.001 1 (1.5) 2 (2.3) >0.999
Dengue duo POCT kit 0 (0.0) 104 (37.7) <0.001 0 67 (35.4) <0.001 0 37 (42.5) <0.001
D.N.P. 3 (1.1) 10 (3.5) 1 (0.5) 9 (4.8) 2 (3) 1 (1.2)
D.N.P. Data not provided by participants, RT-PCR Reverse-transcription polymerase chain reaction, N.A. Not available
P value in bold represents a statistical significant difference
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practice and qualifications), only Dengue duo POCT kits
was found to be independently associated with frequent
use of DDTs (adjusted odds ratio = 2.15, 95% confidence
interval = 1.25–3.69) (Table 3).
Clinical care and practices for dengue
Compared with survey year 2011, significantly smaller
proportion of PCPs referred more than 50% of their
dengue patients to hospital in survey year 2014 (N = 114,
31.4% in 2011 vs. N = 39, 13.3% in 2014; p < 0.001; Table
4). About 45.4% of the PCPs set the platelet count of
≤80,000/mm3 as cut off point for referral to hospital,
although a significant increase was also seen in proportion
of PCPs who uses the platelet count of ≤50,000/mm3
(N = 83, 22.8% in 2011 vs N = 115, 39.2% in 2014;
p < 0.001). Moreover, there was a significant increase in
proportion of PCPs who reviewed dengue patients on
average 5–6 times as part of the dengue management in
survey year 2014 (N = 83, 28.3%) as compared to survey
year 2011 (N = 66, 18.1%; p = 0.003). This trend is similar
among private and public PCPs. About 57–59% of the
PCPs monitored the fluid intake/urine output more than
50% of their time during patient management in both
survey years. Within the public polyclinics, there was a
significant increase in proportion of PCPs in survey year
2014 (N = 59, 67.8%) who monitored the fluid intake/
urine output more than 50% of their time during patient
management compared to survey year 2011 (N = 61,
58.1%; p < 0.001). There was not much difference in the
proportion of PCPs who performed postural blood pressure
monitoring more than 50% of their time during patient
management in general. However, there was a significant
increase (N = 61, 58.1% in 2011 vs N = 59, 67.8% in 2014;
p < 0.001) in proportion of PCPs who performed postural
blood pressure monitoring more than 50% of their time
during patient management in the public PCPs, but a sig-
nificant reduction among private PCPs (N = 126, 49.8% in
2011 vs N = 82, 39.8% in 2014; p = 0.038; Table 4).
Knowledge, attitude and experience toward POCT kits
About 68.9% (N = 202) of the PCPs in survey year 2014
heard about POCT, and 88.1% (N = 258) of the PCPs were
interested to know more about POCT (Table 5). The top
three preferred methods of gaining more information was
through postal information (N = 76, 31.5%), website with
video (N = 70, 29%) and through email and written docu-
mentation (N = 68, 28.2%).
Only 41 (20.3%) out of 202 PCPs who have heard
about POCT had personally experienced using POCT
(Table 6), even though 104 PCPs (Table 2) had reported
using POCT as their preferred method for diagnosis of
dengue. The top three perceived benefits in using POCT
in their clinic were saving patient’s waiting time
(N = 203, 84.2%), helping case management (N = 195,
80.9%) and more accurate diagnosis (N = 137, 56.8). In
addition, the top three perceived challenges in using
POCT in their clinic were “not cost-effective” (N = 61,
25.3%), “existing heavy workload” (N = 41, 17%) and “no
time for training” (N = 32, 13.3%).
The attitude and perception of PCPs were sought in a
qualitatively method on their current usage and imple-
mentation of POCT in the clinic using open ended ques-
tions. Based on the responses received among those PCPs
who are currently using POCT, the common reasons for
usage included “the availability of Dengue duo POCT kit
in their clinic” and “it is a standard test in their clinic”
(Table 7). Other advantages that were highlighted were
“the flexibility to diagnose in both early and late phase of
fever”, “easy to use” and “having accurate result”. In
general, they felt that POCT is useful and two of the PCPs
who responded also highlighted that “patients really ap-
preciate a quick diagnosis”. However, there was also some
PCPs who expressed concerns, despite the current usage
of POCT. They expressed concern about the cost and
accuracy in using POCT as well as the fact that laboratory
tests are likely more accurate than POCT kit.
Among PCPs who have not used POCT in the clinic, they
had the perception that POCT has “very little improvement
Table 3 Factors associated with ‘always’ versus ‘often/sometimes’
behaviour of using Dengue diagnostic test in survey year 2014a
Variables in equation Adjusted Odds Ratio
(95% confidence interval)
P value
Type of Dengue diagnostic test
Other tests Referent
Dengue duo POCT kit 2.15 (1.25–3.69) 0.01
Gender
Male Referent
Female 1.16 (0.69–1.96) 0.57
Age
21–40 years Referent
41–60 years 0.71 (0.38–1.32) 0.27
61 years or above 0.72 (0.24–2.14) 0.56
Place of practice
Private Referent
Polyclinic 0.79 (0.42–1.46) 0.45
Qualifications
M.B.,B.S. (or equivalent) Referent
GDFM 1.05 (0.56–1.95) 0.88
M.Med (Fam. Med.) 1.08 (0.56–2.10) 0.81
MRCP 2.81 (0.30–26.62) 0.37
P values calculated by binary logistic regression. P value in bold represents a
statistical significant association
GDFM Graduate Diploma in Family Medicine, M.Med (Fam. Med.) Master in
Medicine (Family Medicine), MRCP Membership of Royal College of Physicians
a2014 study only
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in patients’ management”, and the current overwhelming
workload of their staffs actually deterred them from using
(Additional file 4: Table S1). A major concern for private
PCPs was the cost of expired kits. For instance, expired kits
will be a loss for their business if there are not enough sus-
pected dengue patients for testing. The lack of an official test
report for their patients’ assurance is also one of the reason
of not using POCT. Moreover, it was highlighted that the
Environmental Health Institute in Singapore provides free
laboratory dengue testing for interested PCPs who are keen
to participate in their dengue surveillance program so there
is no urgency in trying out these POCTs. Despite these con-
cerns, some PCPs anticipated improvements in efficiency of
patient diagnosis after implementing POCT, so they were
keen to use POCT in the near future.
Perception of surge management during dengue largest
spike in 2013
There were two final open-ended questions that focused
on the experience of PCPs during the largest dengue spike
in 2013 (Additional file 4: Table S2) as well as the changes
in disease management since the outbreaks in 2005 and
2007 (Additional file 4: Table S3). In general, physicians
claimed to be more vigilant, ordered full blood count and
dengue diagnosis tests for suspected patients more
Table 4 Dengue clinical management practices among primary care physicians
Overall P value Private practice P value Polyclinic practice P value
2011
N = 364 (%)
2014
N = 293 (%)
2011
N = 253 (%)
2014
N = 206 (%)
2011
N = 105 (%)
2014
N = 87 (%)
Referral to hospital
> 50% 114 (31.4) 39 (13.3) <0.001 99 (39.1) 36 (17.5) <0.001 14 (13.3) 3 (3.4) 0.020
D.N.P. 1 (0.3) 0 1 (0.4) 0 0 0
Usage of platelet count
≤ 100,000/mm3 88 (24.2) 30 (10.2) <0.001 79 (31.2) 29 (14.1) <0.001 8 (7.6) 1 (1.1) 0.042
≤ 80,000/mm3 190 (52.2) 133 (45.4) 0.085 117 (46.2) 101 (49.0) 0.574 70 (66.7) 32 (36.8) <0.001
≤ 50,000/mm3 83 (22.8) 115 (39.2) <0.001 54 (21.3) 66 (32.0) 0.010 27 (25.7) 49 (56.3) <0.001
Platelet count is not an indicator 3 (0.8) 15 (5.1) 0.001 3 (1.2) 10 (4.9) 0.230 0 (0.0) 5 (5.7) 0.018
Average number of clinical review per patient
1–2 64 (17.6) 29 (9.9) 0.005 49 (19.4) 20 (9.7) 0.004 14 (13.3) 9 (10.3) 0.656
3–4 217 (59.6) 171 (58.4) 0.688 140 (55.3) 118 (57.3) 0.775 74 (70.5) 53 (61) 0.172
5–6 66 (18.1) 83 (28.3) 0.003 48 (19) 59 (28.6) 0.020 16 (15.2) 24 (27.6) 0.049
> 6 12 (3.3) 8 (2.7) 0.820 11 (4.3) 7 (3.4) 0.637 1 (1) 1 (1.1) 1.000
D.N.P. 5 (1.4) 2 (0.7) 5 (2) 2 (1) 0 0
Fluid Intake/Urine Output Test
> 50% of the time 208 (57.1) 172 (58.7) 0.751 142 (56.1) 113 (54.9) 0.777 61 (58.1) 59 (67.8) <0.001
D.N.P. 1 (0.3) 0 0 0 1 (1) 0
Use of postural blood pressure
> 50% of the time 179 (49.2) 121 (41.3) 0.049 126 (49.8) 82 (39.8) 0.038 61 (58.1) 59 (67.8) <0.001
D.N.P. Data not provided by participants, RT-PCR reverse-transcription polymerase chain reaction, NA not applicable
P value in bold represents a statistical significant difference
Table 5 Knowledge on point of care rapid Dengue test based
on survey performed in year 2014 (N = 293)
N (%)
Heard about point of care rapid Dengue test
Yes 202 (68.9)
No, Not sure 89 (30.4)
D.N.P. 2 (0.7)
Wish to know more about point of care rapid Dengue test
Yes 258 (88.1)
No 31 (10.6)
D.N.P. 4 (1.3)
Preferred mode of informationa
Postal written information 76 (31.5)
Website with video 70 (29.0)
Email and written demonstration 68 (28.2)
Seminar through demo 41 (17.0)
Public posters 8 (3.3)
Other 4 (1.7)
D.N.P. Data not provided by participants
aMultiple answered allowed
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frequently than before. Although there was a dengue
spike in 2013, 38 of the PCPs reflected that the
situation was still manageable in their clinics. For
confirmed cases, they did close monitoring on full
blood count and other symptoms more frequently.
They also played a more active role in educating
patients on dengue warning signs and the importance
of vector control (Additional file 4: Table S2).
There were 187 PCPs who had practiced during the
earlier smaller dengue spikes in 2004 and 2007. The ma-
jority of them felt that case management has since im-
proved. Majority attributed to the availability of better
dengue diagnosis tests, as well as better awareness of the
disease among the community and doctors. Moreover,
clearer clinical guidelines were also made more available
and accessible to PCPs since then. The PCPs also
highlighted that doctors were more confident in managing
dengue patients as outpatients and so fewer patients were
referred to hospital (Additional file 4: Table S3).
Discussion
Primary care physicians (PCPs) play very important role in
early diagnosis and notification of dengue cases to reduce
dengue transmission and burden [1]. The right knowledge,
attitude and practices on dengue management among
PCPs are critical for dengue control and public education
[16, 17]. Since 2011, there have been advances in provid-
ing better dengue management for suspected dengue
patients in Singapore. Gan et al. in 2014 reported the high
performance of point-of-care diagnostic Dengue duo test
in detecting dengue infection in a clinic setting in
Singapore [15]. Leo et al. in 2013 reported the validation
of the new World Health Organization guideline in
Singapore. The study reported that dengue patients
without any of the seven warning signs as stated in the
guideline may be managed as outpatients, while referral of
patients who presented with any of these warning signs
may lead to over-hospitalization [19].
Over the years between year 2011 and 2014, the propor-
tion of PCPs who always diagnosed dengue using diagnostic
test had increased by about two folds, and those who never
used diagnostic test to confirm dengue fell by about three
folds (Table 3). Compared to private PCPs, all of PCPs from
polyclinics had higher preference to perform diagnostic test
for patients with suspected dengue in 2014. Although Den-
gue duo POCT kit was only introduced in 2013, more than
one third of PCPs had preference to use the POCT kit
based on the survey in 2014. On further assessment, Den-
gue duo POCT test was independently associated with fre-
quent use of diagnostic test after adjusting for age, gender,
level of professional qualification and place of practice. This
highlights the impact of POCT in increasing the usage of
diagnostic test in primary healthcare setting to confirm
dengue for early management of dengue cases as well as for
dengue control via notification to Ministry of Health.
The PCPs emphasized that availability of the POCT kit
at the place of practice, accuracy of the test, rapidness of
results and cost-effectiveness favored its use. The PCPs’
preference to receive more information on diagnostic tests
was through postal mails or website with video demon-
stration on its usage. They were also concerns over the
use of this new POCT kit. These concerns were the lack
of quality control and increased workload in the clinic,
which were also highlighted in another study by Pai et al.
in 2012 [20]. Our findings suggested that further develop-
ment of more accurate and user-friendly test kits, as well
as having highly accessible training platforms for front line
care providers are likely to increase the use of dengue
diagnostic test in both public and private primary health-
care settings to enhance patient management.
After the large dengue epidemic, most PCPs felt that
dengue case management had improved. This was likely
due to the availability of better dengue diagnostic tests,
greater awareness of the disease and clearer clinical
Table 6 Usage on point of care rapid dengue test
N (%)
Usage of point of care rapid dengue test in clinic among
PCPs who knows about it (N = 202)
Yes 41 (20.3)
No 157 (77.7)
D.N.P. 4 (2)
Duration of using point of care rapid dengue test (N = 41)
< 1 month 4 (9.8)
1–3 months 3 (7.2)
> 3 months 30 (73.2)
D.N.P. 4 (9.8)
Benefits perceived by PCPs in using POCT in their clinica
Saves waiting time 203 (84.2)
Helps case management 195 (80.9)
More accurate diagnosis 137 (56.8)
Minimum usage of resources 91 (37.8)
Manage surge in Dengue 87 (36.1)
Don’t know about it 44 (18.3)
Others (benefits) 8 (3.3)
Challenges perceived by PCPs in using POCT in their clinica
Not cost effective 61 (25.3)
Too much workload 41 (17.0)
Too much time for training 32 (13.3)
Not accurate 27 (11.2)
No challenges 26 (10.)
No comment 1 (0.4)
Others (Challenges) 49 (20.3)
D.N.P. Data not provided by participants
aMultiple answered allowed
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guidelines. Compared to the 2011 survey, the survey in
2014 showed PCPs referred patients to hospital with a
lower platelet cut-off of ≤50,000/mm3, which is clinically
more relevant for close monitoring. Similar platelet cut-off
was also reported by Thaver et al. in 2011 amongst the
Pakistanis PCPs [21]. We also found that our Singapore
PCPs became more confident, and committed to managing
the dengue patients as outpatients, with closer monitoring,
where possible. This was reflected in the significant reduc-
tion in patient referrals to hospital and the increased num-
ber of clinical reviews at the primary healthcare setting.
Carrasco et al. in 2011 highlighted that managing dengue
cases in hospital incurred 10 times more cost than ambula-
tory care in Singapore ($600 vs. $60 per day, respectively)
[22]. Lee et al. also reported in 2013 that after the imple-
mentation of the new admission criteria including dengue
outcome calculator which utilizes simple and readily avail-
able clinical information, the proportion of dengue cases
who were being managed as inpatients fell from 91.9% in
2006 to 53.9% in 2008 with saving of US$ 1.4 million in
year 2008 [23]. Similar cost savings to both patients and the
government is likely possible with a significant reduction in
dengue referrals to hospital with the increasing usage of
POCT based on the findings in this study.
We were limited by the fact that there were significant
differences in gender, age groups and the highest qualifica-
tions attained among the PCPs surveyed in 2011 and 2014.
As such, we cannot completely exclude the impact of these
demographic differences. However, regardless of the demo-
graphic differences, the knowledge level on clinical manage-
ment remained high, suggesting that the impact on PCPs’
attitude and practices of dengue diagnosis should be rela-
tively small. We were also limited by the survey method in
collecting more explorative qualitative data. However,
open-ended survey questions provided additional in depth
information about physicians attitudes and experiences on
dengue clinical management and diagnosis. The case man-
agement data that was collected was based on three case
management scenarios (Additional file 3) with the aim to
understand common practices amongst primary care
Table 7 Positive and negative experiences among PCPs who are using or have used POCT before
Themes Frequency Quotes
Positive
Can be used to diagnose in both early
and late phase of fever
36 “NS1 can detect Dengue before D5 fever. IgM/IgG for fever > D5.”
Available 21 “Available in our clinic.”
“This is usually what’s available at our lab.”
Good/Useful 16 “Best thing since sliced bread”
“Useful as a good screening tool when Dengue fever is suspected”
Free 15 “Free test via EHI diagnosis”
Standard test 14 “Standard protocol.”
“Standard test at commercial lab used.”
Rapid result 10 “I love using it. Gives rapid diagnosis on Dengue fever suspect”
Accurate result 5 “Dengue duo- quite happy with it so far accurate.”
Easy to use 5 “Using it seems simple enough.”
Diagnosis in early phase of fever 2 “Very useful for early identification of cases so patients are more likely
to agree to do daily blood for monitoring.”
Patient’s positive opinion 2 “Patients really appreciate a quick diagnosis.”
Cost-effective 1 “I find it useful, fast selective and cost effective.”
Negative
Concern about cost 9 “Given free so used it for trial otherwise expensive”
Concern about accuracy 7 “After doing 3 cases on suspected Dengue- had 2 false negative- not found!”
Troublesome to use 2 “Cumbersome / troublesome to use.”
Trust 2 “I only use it at night or Sunday... Still trust the lab test for Dengue
more than portable kit.”
Other test also used 2 “Has to supplemented by FBC sent to the lab to have haematocrit/platelet.”
Not had occasion to use it much 2 “[used] very little [so] not enough suspected cases seen.”
Only used when instructed to 1 “Have used it during referral to a study in our clinic. But now stopped.”
Lack of official evaluation of it’s efficacy 1 “Lack of official reports.”
Patient’s negative opinion 1 “Patients are still new to the idea of a rapid test kit.”
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physicians. These data will not be able to capture the opti-
mal case management of a suspected dengue case but only
the current preferred case management of a suspected den-
gue case. In fact, Dengue has many overlapping features
with other febrile illnesses. It would be ideal to apply sim-
ple, cheap and easy to use diagnostic test at primary care
sites for optimal case management. In addition, this study
involved only PCPs who were practicing during the 2013
epidemic due to their valid practicing licenses and clinic ad-
dresses. As such, this study is not able to conclude if PCPs
who were not practicing during 2013 epidemic had the
same awareness as those PCPs who were practicing. Last
but not least, the low response rate may not provide a
complete understanding of the changes in KAP on dengue
management after a large dengue epidemic. However, a
comparison on the demographics of PCPs between this
study and another national study published in 2014 [24],
the proportion of PCPs surveyed reflects the general PCPs
reasonably well, although there are more older PCPs than
younger PCPs (<45 years old) in both 2011 and 2014 sur-
veys (Table 1).
Conclusions
After the largest dengue outbreak in 2013, knowledge on
clinical management of dengue remain high, but not higher
between year 2011 and 2014. However, there were signifi-
cant improvements in the diagnosis of dengue, particularly
on the importance of using a diagnostic kit such as the
dengue Duo POCT kit. There were also significant increase
in awareness and practices of the best practices of dengue
clinical management between 2011 and 2014. In order to
improve acceptance & usage of the POCT kit to facilitate
early diagnosis of dengue, it may be worth emphasizing the
importance of continuous medical education via web-based
video trainings and postal information, the sharing of for-
mal evaluations of the diagnostic tests in local settings
through seminars or dialogue sessions, as well as the
support of the local government in providing subsidy for
the usage of POCT kit in the primary healthcare settings.
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